Tonix Pharma (TNXP) Granted European Patent for the Active Ingredient in Tonmya (Cyclobenzaprine HCl Sublingual Tablets)
Tweet Send to a Friend
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) today announced that Tonix has received a European patent (Patent No. 2501234, “Methods and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
